Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Vimizim“
Suchtreffer
Begriffe & Kennungen
Vimizim
Eintrag öffnenVimizim · 4.1 Therapeutic indications · 1
Eintrag öffnenVimizim · 4.3 Contraindications · 1
Eintrag öffnenVimizim · 4.3 · Life-threatening hypersensitivity (anaphylactic reaction) to the active substance or to any of the excipients
Eintrag öffnenVimizim · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenVimizim · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenVimizim · 4.5 · No interaction studies have been performed.
Eintrag öffnenVimizim · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenVimizim · 4.8 Undesirable effects · 1
Eintrag öffnenVimizim · 4.8 · 5 tissue disorders Chills Very common General disorders and Pyrexia Very common administration site conditions
Eintrag öffnenVimizim · 4.8 · All patients developed antibodies to elosulfase alfa in clinical studies. Approximately 80% of patients develo
Eintrag öffnenVimizim · 4.8 · Description of selected adverse reactions
Eintrag öffnenVimizim · 4.8 · Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100),
Eintrag öffnenVimizim · 4.8 · Immunogenicity
Eintrag öffnenVimizim · 4.8 · In patients < 5 years of age, the overall safety profile of Vimizim at 2 mg/kg/week was consistent with the sa
Eintrag öffnenVimizim · 4.8 · MedDRA MedDRA Frequency System organ class Preferred term Immune system disorders Anaphylaxis Uncommon Hyperse
Eintrag öffnenVimizim · 4.8 · Paediatric population
Eintrag öffnenVimizim · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenVimizim · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenVimizim · 4.8 · Summary of the safety profile
Eintrag öffnen